A new blood test, developed by a Raleigh company, can more accurately predict a patient's risk of heart disease than normal cholesterol tests. A Raleigh-based company has developed a new blood test ...
The NMR LipoProfile® test, LipoScience’s first proprietary test, is an FDA-cleared blood test that directly quantifies LDL particle number (LDL-P) and provides physicians and their patients with ...
RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical tests using nuclear magnetic resonance (NMR) ...
Lab testing giant LabCorp, which is based in Burlington, is acquiring Raleigh-based LipoScience in a deal worth some $85 million in cash. Shares in LipoScience, which provides testing services related ...
RALEIGH, N.C. – LipoScience, Inc. has entered into an agreement with ARUP Laboratories, a national clinical and anatomic pathology laboratory, to offer its proprietary NMR LipoProfile test. ARUP ...
Raleigh, NC, March 28, 2008 - The American Diabetes Association (ADA) and the American College of Cardiology (ACC) issued a consensus statement today that states the measurement of LDL particle number ...
LipoScience, Inc., LPDX a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and ...
A new blood test, developed by a Raleigh company, can more accurately predict a patient's risk of heart disease than normal cholesterol tests. A Raleigh-based company has developed a new blood test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results